Page last updated: 2024-12-11
laurencin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
laurencin: extract of sea hare, Aplysia dactylomela; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5363390 |
SCHEMBL ID | 41465 |
MeSH ID | M0068207 |
Synonyms (15)
Synonym |
---|
laurencin |
2h-oxocin-2-methanol,6,7,8-tetrahydro-.alpha.-2-penten-4-ynyl-, acetate, (e)-(.alpha.r,2r,7s,8r)- |
2h-oxocin-2-methanol,6,7,8-tetrahydro-.alpha.-2-penten-4-ynyl-, acetate, [2r-[2.alpha.[r*-(e)],7.beta.,8.alpha.]]- |
2h-oxocin-2-methanol,6,7,8-tetrahydro-.alpha.-2-penten-4-ynyl-, acetate, [2r-[2.alpha.[r*(e)],7.beta.,8.alpha.]]- |
nsc122763 , |
3442-58-8 |
nsc-122763 |
[(e)-1-[(5z)-3-bromo-2-ethyl-3,4,7,8-tetrahydro-2h-oxocin-8-yl]hex-3-en-5-ynyl] acetate |
7-bromo-8-ethyl-3,6,7,8-tetrahydro-alpha-2-penten-4-ynyl-2h-oxocin-2-methanol acetate |
SCHEMBL41465 |
2h-oxocin-2-methanol, 7-bromo-8-ethyl-3,6,7,8-tetrahydro-.alpha.-2-penten-4-ynyl-, acetate, (e)-(.alpha.r,2r,7s,8r)- |
ZFYWONYUPVGTQJ-MUIOLIGRSA-N |
2h-oxocin-2-methanol, 7-bromo-8-ethyl-3,6,7,8-tetrahydro-.alpha.-2-penten-4-ynyl-, acetate, (e)-(alphar,2r,7s,8r)- |
(3e)-1-(7-bromo-8-ethyl-3,6,7,8-tetrahydro-2h-oxocin-2-yl)-3-hexen-5-ynyl acetate # |
2h-oxocin-2-methanol, 7-bromo-8-ethyl-3,6,7,8-tetrahydro-.alpha.-2-penten-4-ynyl-, acetate, [2r-[2.alpha.[r*(e)],7.beta.,8.alpha.]]- |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 84.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (84.25) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |